Effects of Different Doses of 131I on Clinical Response and Immune Function in Patients with Low to Medium-Risk of Differentiated Thyroid Cancer After Ablative Treatment

HE Jian, CHEN Qian, LI Pan, ZHANG Shuang, YAO Yutang

PDF(950 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(950 KB)
Labeled Immunoassays and Clinical Medicine ›› 2022, Vol. 29 ›› Issue (4) : 613-617. DOI: 10.11748/bjmy.issn.1006-1703.2022.04.016
Clinical Investigation

Effects of Different Doses of 131I on Clinical Response and Immune Function in Patients with Low to Medium-Risk of Differentiated Thyroid Cancer After Ablative Treatment

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 29(4): 613-617 https://doi.org/10.11748/bjmy.issn.1006-1703.2022.04.016

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(950 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备18063657号-2
Copyright © Labeled Immunoassays and Clinical Medicine, All Rights Reserved.
Tel: 010-68515701,68517801　E-mail: bjmy@circ.com.cn

/

〈 〉